Keyphrases
During Pregnancy
100%
Low Molecular Weight Heparin
100%
Heparin Therapy
100%
Placental Growth Factor (PlGF)
100%
Pregnant Women
44%
Soluble Fms-like Tyrosine kinase-1 (sFlt-1)
44%
Soluble Endoglin
33%
Anticoagulant Therapy
22%
Maternal Plasma
22%
Placenta-mediated Pregnancy Complications
22%
Third Trimester
11%
Treatment Group
11%
Treatment Control
11%
Angiogenic
11%
Prospective Cohort Study
11%
Plasma Concentration
11%
Pregnancy Complications
11%
Gestational Age
11%
Plasma Samples
11%
Circulating Levels
11%
Thromboprophylaxis
11%
Healthy Pregnant Women
11%
Clinically Indicated
11%
Anticoagulation Treatment
11%
Medicine and Dentistry
Low Molecular Weight Heparin
100%
Heparinization
100%
Placental Growth Factor
100%
Protein Tyrosine Kinase
44%
Endoglin
33%
Anticoagulant Therapy
22%
Pregnancy
22%
Placenta
22%
Maternal Plasma
22%
Group Therapy
11%
Enzyme Linked Immunosorbent Assay
11%
Recurrent Disease
11%
Anticoagulation
11%
Third Trimester Pregnancy
11%
Complication of Pregnancy
11%
Gestational Age
11%
Prospective Cohort Study
11%
Thromboprophylaxis
11%
Biochemistry, Genetics and Molecular Biology
Molecular Weight
100%
Heparin
100%
Placental Growth Factor
100%
Soluble Fms-Like Tyrosine Kinase-1
44%
Endoglin
33%
Anticoagulation
33%
Pregnancy
22%
Blood Level
11%
Prospective Cohort Study
11%
Third Trimester Pregnancy
11%
Immunology and Microbiology
Molecular Weight
100%
Placental Growth Factor
100%
Anticoagulation
33%
Endoglin
33%
Placenta
22%
Pregnancy
22%
Maternal Plasma
22%
Blood Level
11%
ELISA
11%
Third Trimester Pregnancy
11%
Pharmacology, Toxicology and Pharmaceutical Science
Low Molecular Weight Heparin
100%
Placental Growth Factor
100%
Protein Tyrosine Kinase
44%
Endoglin
33%
Anticoagulation Therapy
22%
Recurrent Disease
11%
Enzyme-Linked Immunosorbent Assay
11%
Prospective Cohort Study
11%